Nanophase Technologies (OTCMKTS:NANX – Get Free Report) and BioHarvest Sciences (NASDAQ:BHST – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.
Earnings and Valuation
This table compares Nanophase Technologies and BioHarvest Sciences”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nanophase Technologies | $37.30 million | 0.00 | -$4.39 million | $0.05 | N/A |
| BioHarvest Sciences | $34.51 million | 1.43 | -$11.14 million | ($0.59) | -4.25 |
Risk and Volatility
Nanophase Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations for Nanophase Technologies and BioHarvest Sciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nanophase Technologies | 0 | 0 | 0 | 0 | 0.00 |
| BioHarvest Sciences | 1 | 0 | 1 | 0 | 2.00 |
BioHarvest Sciences has a consensus target price of $10.00, indicating a potential upside of 298.41%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than Nanophase Technologies.
Profitability
This table compares Nanophase Technologies and BioHarvest Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nanophase Technologies | 5.59% | 31.49% | 6.67% |
| BioHarvest Sciences | -32.54% | -76.03% | -25.30% |
Institutional and Insider Ownership
70.2% of Nanophase Technologies shares are owned by institutional investors. 5.1% of Nanophase Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Nanophase Technologies beats BioHarvest Sciences on 10 of the 13 factors compared between the two stocks.
About Nanophase Technologies
Nanophase Technologies Corporation, a science-driven company, develops, manufactures, and sells integrated family of nanomaterial technologies in the United States. It engages in engineered materials, formulation development, and commercial manufacturing. The company produces engineered nanomaterial products comprising antimony, bismuth, cerium, iron, and zinc oxide for use in a various markets, including surface finishing,exterior coatings, personal care, plastics, scratch resistant coatings, and textiles. It also provides skin care formulations with mineral-based UV protection under the under the Solésence brand; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Receive News & Ratings for Nanophase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanophase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
